Compare GFL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GFL | MEDP |
|---|---|---|
| Founded | 2007 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9B | 12.9B |
| IPO Year | 2019 | 2016 |
| Metric | GFL | MEDP |
|---|---|---|
| Price | $44.68 | $471.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 13 |
| Target Price | $56.60 | ★ $498.25 |
| AVG Volume (30 Days) | ★ 1.5M | 435.8K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 0.14% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 15.28 |
| Revenue | N/A | N/A |
| Revenue This Year | $7.27 | $13.11 |
| Revenue Next Year | $7.12 | $7.51 |
| P/E Ratio | ★ $5.95 | $30.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.83 | $250.05 |
| 52 Week High | $52.00 | $628.92 |
| Indicator | GFL | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 43.76 |
| Support Level | $42.34 | $457.41 |
| Resistance Level | $46.13 | $501.30 |
| Average True Range (ATR) | 1.14 | 17.34 |
| MACD | 0.22 | 7.68 |
| Stochastic Oscillator | 79.18 | 87.87 |
GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.